In such a condition, BNIP3 downregulation further exacerbated mitochondrial damage and contributed to muscle atrophy, suggesting that in chronic aging sarcopenia, increased BNIP3 represents an adaptive response aimed at removing damaged mitochondria. This evidence concerns the gene BNIP3 and sarcopenia.